Showing results (121-130 of 529) with videos related to

Sort By:
Pageof 53
European Heart Journal. Cardiovascular Pharmacotherapy|March 30, 2022
Platelet P2Y12 inhibiting therapy in adjunct to vascular dose of rivaroxaban or aspirin: a pharmacodynamic study of dual pathway inhibition vs. dual antiplatelet therapyMattia Galli, Francesco Franchi, Fabiana Rollini, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|January 13, 2023
Cardiovascular, renal, and lower limb outcomes in patients with type 2 diabetes after percutaneous coronary intervention and treated with sodium-glucose cotransporter 2 inhibitors vs. dipeptidyl peptidase-4 inhibitorsHsin-Fu Lee, Yi-Hsin Chan, Chi Chuang, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|January 13, 2023
Finerenone and effects on mortality in chronic kidney disease and type 2 diabetes: a FIDELITY analysisGerasimos Filippatos, Stefan D Anker, Phyllis August, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|January 14, 2023
Antithrombotic therapy and cardiovascular outcomes after transcatheter aortic valve implantation in patients without indications for chronic oral anticoagulation: a systematic review and network meta-analysis of randomized controlled trialsPaul Guedeney, Vincent Roule, Jules Mesnier, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|April 28, 2020
Motivational Interviewing to Support Oral AntiCoagulation adherence in patients with non-valvular Atrial Fibrillation (MISOAC-AF): a randomized clinical trialApostolos Tzikas, Athanasios Samaras, Anastasios Kartas, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|May 8, 2020
Choices in antithrombotic management for patients with atrial fibrillation undergoing percutaneous coronary intervention: questions (and answers) in chronological sequenceAndrea Rubboli, Marco Valgimigli, Davide Capodanno, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|August 23, 2021
Incidence, associated outcomes, and predictors of upper gastrointestinal bleeding following acute myocardial infarction: a SWEDEHEART-based nationwide cohort studyPhilip Sarajlic, Moa Simonsson, Tomas Jernberg, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|April 11, 2020
Indirect comparison of the efficacy and safety of alirocumab and evolocumab: a systematic review and network meta-analysisPaul Guedeney, Sabato Sorrentino, Gennaro Giustino, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|August 18, 2016
Angiotensin receptor neprilysin inhibitor LCZ696: a novel targeted therapy for arterial hypertension?Vasiliki Katsi, Georgios Skalis, Antonis N Pavlidis, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|August 18, 2016
From proprotein convertase subtilisin/kexin type 9 to its inhibition: state-of-the-art and clinical implicationsEliano P Navarese, Michalina Kołodziejczak, Dimitrios Dimitroulis, et al.
Pageof 53